Pharmaceutical Market Access in CEE / CIS / Asia: Market Access

Showing posts with label Market Access. Show all posts

Big Pharma Gets Boost as China Speeds Up New Drug Approvals

For decades, Chinese patients have struggled to gain access to cutting-edge medicines thanks to bureaucratic delays that have hamstrung...

Iran has one of the longest histories of medical practice in the world. The ancient Mesopotamians, for example, were carving diagnoses...

Pharmaceutical Product Registration Marketing of new drugs in Turkey is governed by the regulatory procedures prescribed by the Pharma...

Key Issues of Concern: Intellectual property protections: Patents and data protection relating to pharmaceuticals have been official...

On September 16, 2014, the Ukrainian and European parliaments ratified the EU–Ukraine Association Agreement (AA), providing for harmoni...

Government Price Controls. PhRMA‘s members are extremely concerned about the general lack of access to health care in India. For a co...

PhRMA and its member companies acknowledge the challenges India faces in extending healthcare access to its large and growing populatio...

State Regulation of Prices of Medicines on the Essential Drug List (EDL) and Reimbursement Debate In February 2013, the Russian Ministr...

PhRMA and its member companies operating in Russia face numerous market access barriers in Russia, especially in government procurement a...